Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
2.

Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults.

Yin Z, Fujii H, Walshe T.

Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006. Epub 2010 Aug 21.

PMID:
20732368
3.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
4.

Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.

Søndergaard H, Coquet JM, Uldrich AP, McLaughlin N, Godfrey DI, Sivakumar PV, Skak K, Smyth MJ.

J Immunol. 2009 Dec 1;183(11):7326-36. doi: 10.4049/jimmunol.0902697. Epub 2009 Nov 13.

5.

IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells.

Sayeh E, Sterling K, Speck E, Freedman J, Semple JW.

Blood. 2004 Apr 1;103(7):2705-9. Epub 2003 Dec 4. Erratum in: Blood. 2004 May 15;103(10):3643.

6.

Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses.

Ma YH, Cheng WZ, Gong F, Ma AL, Yu QW, Zhang JY, Hu CY, Chen XH, Zhang DQ.

World J Gastroenterol. 2008 Sep 14;14(34):5274-81.

7.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
8.

IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.

Motegi A, Kinoshita M, Inatsu A, Habu Y, Saitoh D, Seki S.

J Leukoc Biol. 2008 Oct;84(4):1047-56. doi: 10.1189/jlb.0807530. Epub 2008 Jul 23.

PMID:
18653461
9.

Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.

Lee CH, Chiang YH, Chang SE, Chong CL, Cheng BM, Roffler SR.

Clin Cancer Res. 2009 Apr 15;15(8):2756-66. doi: 10.1158/1078-0432.CCR-08-2311. Epub 2009 Mar 24.

10.

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y.

Cancer Immunol Immunother. 2007 Aug;56(8):1251-64. Epub 2007 Jan 23.

PMID:
17242927
11.

Immunology. Stress, NK receptors, and immune surveillance.

Pardoll DM.

Science. 2001 Oct 19;294(5542):534-6. Epub 2001 Sep 20. No abstract available.

PMID:
11567108
12.

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.

Kowalczyk A, Wierzbicki A, Gil M, Bambach B, Kaneko Y, Rokita H, Repasky E, Fenstermaker R, Brecher M, Ciesielski M, Kozbor D.

Cancer Immunol Immunother. 2007 Sep;56(9):1443-58. Epub 2007 Feb 14.

PMID:
17597331
14.

Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas.

Davis M, Conlon K, Bohac GC, Barcenas J, Leslie W, Watkins L, Lamzabi I, Deng Y, Li Y, Plate JM.

J Immunother. 2012 Oct;35(8):629-40.

PMID:
22996369
15.

The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses.

Crespo FA, Sun X, Cripps JG, Fernandez-Botran R.

J Leukoc Biol. 2006 Mar;79(3):586-95. Epub 2006 Jan 13.

PMID:
16415169
16.

Regulation of interferon-gamma during innate and adaptive immune responses.

Schoenborn JR, Wilson CB.

Adv Immunol. 2007;96:41-101. Review.

PMID:
17981204
17.

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.

Gut. 2009 Jul;58(7):974-82. doi: 10.1136/gut.2008.163600. Epub 2009 Feb 6.

PMID:
19201769
18.

Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.

Cerboni C, Ardolino M, Santoni A, Zingoni A.

Blood. 2009 Mar 26;113(13):2955-64. doi: 10.1182/blood-2008-06-165944. Epub 2009 Jan 5.

19.

Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.

Miyagi T, Takehara T, Tatsumi T, Suzuki T, Jinushi M, Kanazawa Y, Hiramatsu N, Kanto T, Tsuji S, Hori M, Hayashi N.

Hepatology. 2004 Nov;40(5):1190-6.

PMID:
15486936
20.

Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.

Preynat-Seauve O, Contassot E, Schuler P, French LE, Huard B.

Melanoma Res. 2007 Jun;17(3):169-76.

PMID:
17505262

Supplemental Content

Support Center